Skip to content

Clinical trials

Phase 2 Polycythemia Vera trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polycythemia Vera Phase: Phase 2 Country / region: United States Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20024
20042
20055
20065
20072
20081
20092
20101
20113
20122
20132
20144
20154
20172
20182
20193
20202
20214
20221
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Terminated14
Recruiting6
Active, not recruiting5
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center12
Fred Hutchinson Cancer Center6
National Cancer Institute (NCI)6
H. Lee Moffitt Cancer Center and Research Institute3
Hoffmann-La Roche2
Mayo Clinic2
Roswell Park Cancer Institute2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2
Sierra Oncology LLC - a GSK company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polycythemia Vera67
Primary Myelofibrosis49
Thrombocythemia, Essential42
Myeloproliferative Disorders31
Leukemia, Myelomonocytic, Chronic20
Leukemia, Myeloid, Acute19
Leukemia, Lymphocytic, Chronic, B-Cell18
Myelodysplastic Syndromes18
Multiple Myeloma16
Precursor Cell Lymphoblastic Leukemia-Lymphoma15

Trials

Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.